← Back to Patent Explorer
US4177188A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for recovering purified albumin from blood plasma using PEG and caprylic acid

Assignee: Nordisk Insulinlaboratorium
•
Filing: 1978-01-10
•
Granted: 1979-12-04
•
Expires: 1998-01-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process is disclosed for the recovery of albumin in very high purity from human blood plasma by treatment of the blood plasma with polyethylene glycol (PEG) to precipitate out impurities followed by thermocoagulation of a resulting supernatant aqueous solution containing PEG and albumin in the presence of caprylic acid and isolation of the purified albumin by precipitation.

Inventors

  • 👤 Jorgen F. Hansen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:57
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/76; C07K14/765; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 145 words
A process for recovering purified albumin suitable for intravenous injection from human blood plasma without denaturing the globulins present therein, comprising the steps of: (a) mixing the blood plasma with 150 to 300 g polyethylene glycol (PEG) per liter of liquid mixture and adjusting the mixture to a pH of 6 to 7 for precipitating fibrinogen and globulins while forming a supernatant containing albumin; (b) separating the supernatant from the formed precipitate; (c) adjusting the pH of the supernatant to a pH of 4.5 to 5.3; for precipitating albumin; (d) redissolving the albumin with entrained PEG in an aqueous medium; (e) subjecting the resulting albumin solution formed during step (d) to thermocoagulation at 50 to 65° C. and a pH of 4.6 to 5.0 in the presence of a stabilzing amount of caprylic acid; and (f) isolating the purified albumin from the solution by precipitation.
Claim 2
Dependent Claim 145 words
A process for recovering purified albumin suitable for intravenous injection from human blood plasma without denaturing the globulins present therein, comprising the steps of: (a) mixing the blood plasma with 150 to 300 g polyethylene glycol (PEG) per liter of liquid mixture and adjusting the mixture to a pH of 6 to 7 for precipitating fibrinogen and globulins while forming a supernatant containing albumin; (b) separating the supernatant from the formed precipitate; (c) adjusting the pH of the supernatant to a pH of 4.5 to 5.3; for precipitating albumin; (d) redissolving the albumin with entrained PEG in an aqueous medium; (e) subjecting the resulting albumin solution formed during step (d) to thermocoagulation at 50 to 65° C. and a pH of 4.6 to 5.0 in the presence of a stabilzing amount of caprylic acid; and (f) isolating the purified albumin from the solution by precipitation.
Claim 3
Dependent Claim 29 words
A process according to claim 1, wherein PEG is used in an amount of 180 to 200 g PEG per liter liquid supernatant obtained after precipitating fibrinogen and globulins.
Claim 4
Dependent Claim 32 words
A process according to claim 1, wherein the caprylic acid is used in an amount of 2 to 3 g caprylic acid per liter of the solution of albumin during the thermocoagulation.

References Cited (Backward Citations)

US2705230A Cited
US2765299A Cited
US3415804A Cited
US3790552A Cited
US3992367A Cited
US3926939A Cited
US4017470A Cited
GB1480184A Cited
US4025500A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-12-03 1983-06-04 1983-12-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-12-03 1987-06-04 1987-12-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-12-03 1991-06-04 1991-12-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag